跳至主要内容
临床试验/NCT05292482
NCT05292482已完成不适用

Pragmatic Randomized Controlled Trial of Pharmacopuncture Therapy for Adhesive Capsulitis : A Pilot Study

Jaseng Hospital of Korean Medicine2 个研究点 分布在 2 个国家目标入组 21 人开始时间: 2022年4月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
21
试验地点
2
主要终点
Numeric rating scale (NRS) of shoulder pain

研究概览

简要总结

This is a 2-arm parallel pragmatic randomized controlled trial that will compare pharmacopuncture therapy with physical therapy for adhesive capsulitis.

详细描述

Participants who voluntarily signed informed consent form and eligible for the study were randomly assigned in a 1:1 ratio (25:25) for pharmacopuncture therapy and physical therapy group. Participants of each group will receive twice a week for total 6 weeks of intervention. This is a pragmatic randomized controlled trial, so physicians will have medical decision making according to each participant's conditions.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
19 Years 至 69 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Limitation of the shoulder movement (active or passive)
  • Numeric Rating Scale (NRS) of neck pain is more than 5
  • Symptoms of adhesive capsulitis for more than 1 month
  • Discrimination findings which can explain clinical symptoms on shoulder MRI or CT
  • 19-69 years old
  • participants who agreed and wrote informed consents

排除标准

  • Case of being diagnosed with a specific serious disease that may cause shoulder pain(Fracture, Dislocation, etc.)
  • Cause of pain due to soft tissue disease, not the spine(Cancer, fibromyalgia, RA, goat, or etc.) Other chronic diseases(stroke, MI, kidney disease, diabetic neuropathy, dimentia, epilepsy, or etc.) that may interfere with the interpretation of therapeutic effects or outcomes
  • Participants taking steroid, immunosuppressant, psychotropic medication, or taking other drugs that may affect outcomes
  • Inappropriate or unsafe pharmacopuncture therapy; hemorrhagic disease, taking anticoagulant drug, or severe diabetes patients who are likely to be infected
  • Participants who took NSAIDs or pharmacopuncture, acupuncture, physical therapy within 1 week
  • Pregnant, planning to get pregnant or lactating women
  • Participants who had undergone shoulder surgery within 3 months
  • Participants who had participated in other clinical trial within 1 month, had participated in other study within 6 months from the date of selection, or have plan for participation in other trial during follow up period of this trial
  • Participants who can not write informed consent
  • Participants who is difficult to participate in the trial according to investigator's decision

结局指标

主要结局

Numeric rating scale (NRS) of shoulder pain

时间窗: week 7

NRS is a pain scale in which the patient indicates their subjective pain as a whole number from 0 to 10, where 0 indicates 'no pain or discomfort' and 10 indicates 'the most severe pain and discomfort imaginable'.

次要结局

  • Visual analogue scale (VAS) of shoulder pain(week 1, 2, 3, 4, 5, 6, 7, 13)
  • SPADI(week 1, 7, 13)
  • SF-12 v2(week 1, 7, 13)
  • EQ-5D-5L(week 1, 7, 13)
  • ROM(Range of motion)(week 1, 2, 3, 4, 5, 6, 7, 13)
  • PGIC(week 7, 13)

研究者

发起方
Jaseng Hospital of Korean Medicine
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验